Results 11 to 20 of about 70,470 (286)
NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients [PDF]
BMC GeriatricsBackground N-terminal pro-B-type natriuretic peptide (NT-proBNP) is useful to predict adverse outcomes. Change in NT-proBNP level may provide additional actionable risk assessment information. This study aimed to determine the association of change in NT-
Jinling Ma, Ang Li, Suyan Bian
doaj +2 more sources
Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD [PDF]
Indian Pacing and Electrophysiology JournalAims: Plasma NT-proBNP is an established marker of heart failure. Previous studies suggested urinary NT-proBNP has potential as marker of chronic heart failure as well. The objective of this study was to compare urinary NT-proBNP to plasma NT-proBNP in a
Benedikt Seither +14 more
doaj +2 more sources
ESC Heart FailureAims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH.
Oliver Dörr +15 more
doaj +2 more sources
ESC Heart Failure, 2021 Aims This multicentre study investigated the association of periprocedural changes in the levels of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) with clinical outcomes after transcatheter edge‐to‐edge mitral valve repair (TMVR).
Tetsu Tanaka +12 more
doaj +1 more source
The Egyptian Heart Journal, 2023 Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker used for the diagnosis of heart failure. There is a relationship between NT-proBNP levels and body mass index (BMI). The study aimed to explore the impact of BMI on NT-proBNP
Tuan Ha Manh, Duong Do Anh, Tung Le Viet
doaj +1 more source
The Ratio of NT-proBNP to CysC1.53 Predicts Heart Failure in Patients With Chronic Kidney Disease
Frontiers in Cardiovascular Medicine, 2021 Background: The N-terminal pro B type natriuretic peptide (NT-proBNP) is important for prognosis of heart failure in patients with chronic kidney disease (CKD).
Sheng Wang +10 more
doaj +1 more source
Journal of the American College of Cardiology, 2016 BACKGROUND: Pulmonary hypertension (PH) is a serious complication to interstitial lung disease (ILD) and has a poor prognosis. PH is often diagnosed by screening with echocardiography followed by right heart catheterisation. A previous study has shown that a value of NT-pro-brain natriuretic peptide (NT-proBNP) <95 ng/l could be used to rule out PH ...
Andersen, Charlotte +3 more
openaire +3 more sources
Scientific Reports, 2022 N-terminal prohormone of brain natriuretic peptide (NT-proBNP) is an established biomarker for diagnosis of heart failure. The study aims to explore whether known cardiovascular risk factors, including education and income as indicators of socioeconomic ...
Emanuel Matusch +7 more
doaj +1 more source
ESC Heart Failure, 2021 Aims Guidelines support the role of B‐type natriuretic peptide (BNP) and amino‐terminal pro‐BNP (NT‐proBNP) for risk stratification of patients in programmes to prevent heart failure (HF).
Claire Sweeney +10 more
doaj +1 more source
A Multi-marker Model for Predicting Decompensated Heart Failure in Patients with Prior Acute Myocardial Infarction [PDF]
, 2020 The aim of the study was to assess the prognostic value of determining the plasma concentration of NT-proBNP and ST2 in the patients with decompensated HF and prior acute myocardial infarction and their combination in this category of patients.Materials ...
Levandovska, K. (Khrystyna)
core +3 more sources